相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Study of the intracellular delivery mechanism of a pH-sensitive peptide modified with enhanced green fluorescent protein
Po-Chuan Chiu et al.
JOURNAL OF DRUG TARGETING (2020)
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection
Wazir Abdullahi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Ischemia-Reperfusion Injury After Endovascular Thrombectomy for Ischemic Stroke
Maxime Gauberti et al.
STROKE (2018)
Cell-Penetrating Peptides: From Basic Research to Clinics
Giulia Guidotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Acute Ischemic Stroke Therapy Overview
Luciana Catanese et al.
CIRCULATION RESEARCH (2017)
Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells
Tzyy-Harn Yeh et al.
MOLECULAR PHARMACEUTICS (2016)
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
Hans C. Helms et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Targeted erythropoietin selectively stimulates red blood cell expansion in vivo
Devin R. Burrill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Erythropoietin in Stroke Therapy: Friend or Foe
Rhonda Souvenir et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Widespread Expression of Erythropoietin Receptor in Brain and Its Induction by Injury
Christoph Ott et al.
MOLECULAR MEDICINE (2015)
Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
Sofie Stalmans et al.
PLOS ONE (2015)
Pathogens Penetrating the Central Nervous System: Infection Pathways and the Cellular and Molecular Mechanisms of Invasion
Samantha J. Dando et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Intracellular Delivery of Recombinant Arginine Deiminase (rADI) by Heparin-Binding Hemagglutinin Adhesion Peptide Restores Sensitivity in rADI-Resistant Cancer Cells
Fe-Lin Lin Wu et al.
MOLECULAR PHARMACEUTICS (2014)
Targeted Delivery of Erythropoietin by Transcranial Focused Ultrasound for Neuroprotection against Ischemia/Reperfusion-Induced Neuronal Injury: A Long-Term and Short-Term Study
Sheng-Kai Wu et al.
PLOS ONE (2014)
Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Li-Li Zou et al.
CURRENT NEUROPHARMACOLOGY (2013)
Effects of erythropoietin on STAT1 and STAT3 levels following cerebral ischemia-reperfusion in rats
Chunjuan Jiang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2013)
Rab GTPases Regulate Endothelial Cell Protein C Receptor-Mediated Endocytosis and Trafficking of Factor VIIa
Ramesh C. Nayak et al.
PLOS ONE (2013)
Adsorptive-Mediated Brain Delivery Systems
Wei Lu
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Erythropoietin: still on the neuroprotection road
Nelvys Subiros et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS
Sandra R. Alcala-Barraza et al.
JOURNAL OF DRUG TARGETING (2010)
Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse
Ruben J. Boado et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Subcellular targeting strategies for drug design and delivery
Lawrence Rajendran et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Enhanced Delivery of Erythropoietin Across the Blood-Brain Barrier for Neuroprotection Against Ischemic Neuronal Injury
Feng Zhang et al.
TRANSLATIONAL STROKE RESEARCH (2010)
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Hannelore Ehrenreich et al.
STROKE (2009)
CNS Delivery Via Adsorptive Transcytosis
Francoise Herve et al.
AAPS JOURNAL (2008)
Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia
Y. Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies
Jie Pan et al.
NEURORADIOLOGY (2007)
Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis
SK Jain et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions
FD Menozzi et al.
MICROBES AND INFECTION (2006)
Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia
YP Yu et al.
NEUROSCIENCE LETTERS (2005)
Emerging biological roles for erythropoietin in the nervous system
M Brines et al.
NATURE REVIEWS NEUROSCIENCE (2005)
New technologies for drug delivery across the blood brain barrier
AV Kabanov et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption
S Warach et al.
STROKE (2004)
Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique
H Yamamoto et al.
EXPERIMENTAL NEUROLOGY (2003)
The pleiotropic effects of erythropoietin in the central nervous system
M Buemi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Erythropoietin therapy for acute stroke is both safe and beneficial
H Ehrenreich et al.
MOLECULAR MEDICINE (2002)
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
ML Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)